Premier Path Wealth Partners LLC Increases Position in Colgate-Palmolive (NYSE:CL)

Premier Path Wealth Partners LLC grew its holdings in Colgate-Palmolive (NYSE:CL) by 11.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,240 shares of the company’s stock after purchasing an additional 332 shares during the period. Premier Path Wealth Partners LLC’s holdings in Colgate-Palmolive were worth $295,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Integrated Investment Consultants LLC lifted its holdings in Colgate-Palmolive by 88.5% during the 4th quarter. Integrated Investment Consultants LLC now owns 25,566 shares of the company’s stock valued at $2,324,000 after buying an additional 12,000 shares in the last quarter. Arkadios Wealth Advisors raised its holdings in shares of Colgate-Palmolive by 11.7% in the fourth quarter. Arkadios Wealth Advisors now owns 6,476 shares of the company’s stock valued at $589,000 after acquiring an additional 678 shares in the last quarter. Canoe Financial LP raised its holdings in shares of Colgate-Palmolive by 5.0% in the 4th quarter. Canoe Financial LP now owns 88,646 shares of the company’s stock valued at $8,059,000 after purchasing an additional 4,200 shares in the last quarter. Folger Nolan Fleming Douglas Capital Management Inc. boosted its position in Colgate-Palmolive by 6.1% during the 4th quarter. Folger Nolan Fleming Douglas Capital Management Inc. now owns 5,714 shares of the company’s stock valued at $519,000 after acquiring an additional 330 shares in the last quarter. Finally, Arthur M. Cohen & Associates LLC raised its position in shares of Colgate-Palmolive by 8.2% in the 4th quarter. Arthur M. Cohen & Associates LLC now owns 2,650 shares of the company’s stock worth $241,000 after acquiring an additional 200 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Up 0.3 %

Colgate-Palmolive stock opened at $88.79 on Monday. The stock’s 50 day simple moving average is $92.20 and its two-hundred day simple moving average is $97.75. Colgate-Palmolive has a 12 month low of $79.69 and a 12 month high of $109.30. The firm has a market cap of $72.55 billion, a PE ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.25%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 57.31%.

Insider Activity

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.34% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on CL shares. JPMorgan Chase & Co. cut their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research note on Thursday. Piper Sandler cut their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. UBS Group cut their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday. Finally, Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $101.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.